Condition
Acute Pancreatic Necrosis
Total Trials
4
Recruiting
1
Active
1
Completed
3
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 4 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
33%
1 of 3 completed with results
Key Signals
1 with results100% success
Data Visualizations
Phase Distribution
2Total
Not Applicable (2)
Trial Status
Completed3
Recruiting1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (4)
Showing 4 of 4 trials
NCT06553651Not ApplicableRecruiting
Necrosectomy With Cryotechnology for Accelerated Removal
NCT07023055CompletedPrimary
Serum TAM Receptor Tyrosine Kinase Ligands in Acute Pancreatitis
NCT04747990Completed
coMpliAnce With evideNce-based cliniCal Guidelines in the managemenT of Acute biliaRy pancreAtitis
NCT03694210Not ApplicableCompletedPrimary
EndoRotor DEN (Direct Endoscopic Necrosectomy)Trial
Showing all 4 trials